InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-18.7%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Migliarese Antonio, Chief Financial Officer. Insider active across 1 company, notably CytoDyn Inc.. Aggregated, 15 filings have been recorded. History available since 6 August 2021. The latest transaction was disclosed on 30 November 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations15 total
12,008 shares0Common StockSEC:0001104659-22-123366:0
10,807 shares0Common StockSEC:0001104659-22-119981:0
12,714 shares0Common StockSEC:0001104659-22-114100:0
9,824 shares0Common StockSEC:0001104659-22-109690:0
10,292 shares0Common StockSEC:0001104659-22-105981:0
7,086 shares0Common StockSEC:0001104659-22-101256:0
8,313 shares0Common StockSEC:0001104659-22-097604:0
5,208 shares0Common StockSEC:0001104659-22-092173:0
5,614 shares0Common StockSEC:0001104659-22-086125:0
9,824 shares0Common StockSEC:0001104659-22-080837:0
10,292 shares0Common StockSEC:0001104659-22-077435:0
10,807 shares0Common StockSEC:0001104659-22-073010:0
11,683 shares0Common StockSEC:0001104659-22-069294:0
3,023 shares0Common stockSEC:0000899243-21-032387:0
3,023 shares0Common stockSEC:0000899243-21-032387
15 of 15 declarations
About Migliarese Antonio
Antonio Migliarese is the Chief Financial Officer and Interim President at CytoDyn Inc. He oversees the financial operations of the company, ensuring compliance and integrity in financial reporting. His expertise is crucial for CytoDyn's financial strategy.
